Joinstar Biomedical Technology Co., Ltd.
Founded in December 2010, with a total investment of 43 million USD, a total construction area of 45929 square meters and aregistered capital of 12 million USD, Joinstar Biomedical Technology Co., Ltd. is a biomedical technology enterprise focusing on medical in vitro diagnostic products. Joinstar has established a strategic partnership with Morgan Stanley, Including Zhejiang provincial postdoctoral workstation, liquid-phase chip Institute, and Zhejiang provincial centralized supervision platform for Importing & Exporting of special biological products. The company now has a complete set of R & D, production equipment and purification workshop for in vitro diagnostic instruments / reagents / raw materials for POCT, biochemistry, immunity and molecular diagnosis, with an annual production capacity of 20 million diagnostic kits per shift, a 8668 square meters IVD reagent production base and a 1700 square meters public experimental platform. There are 435 employees, accounting for 60% of bachelor degree or above, including nearly 80 doctors, masters and senior titles. 73 patents have been applied for or authorized, including 30 invention patents and 12 international patents. Has obtained 45 NMPA medical device product registration certificates, 29 CE certificates, and more than 40 products under research and registration. The products are sold in more than 50 countries amount the world and 30 provinces, municipalities and autonomous regions in China. It has established a relatively perfect marketing channel with nearly 7000 customers